A recent study evaluated the effects of SGLT-2i and other glucose-lowering drugs on cardiovascular event outcomes in patients with type 2 diabetes from 6 countries in 3 world regions.
Researchers examined the effect of menopausal hormone therapy on left ventricular and left atrial chamber structure and function changes, which are markers of subclinical cardiovascular disease.
Researchers evaluated the association between low maternal vitamin D status in early pregnancy and the likelihood of childhood obesity in the offspring.
In patients with type 2 diabetes and heart failure, primary prevention with aspirin reduced all-cause mortality but increased nonfatal myocardial infarction and stroke.
Results comparing the prevalence of obesity amongst adolescents with the rate of bariatric surgeries were presented at ENDO 2018.
Young adults with type 1 or type 2 diabetes saw improvements in HbA1c and psychosocial well-being after occupational therapy.
Researchers identified several patient factors that independently predict the likelihood of insulin initiation in patients with type 2 diabetes.
Researchers observed a significant trend for cognitive decline in individuals with prediabetes and diabetes over a 10-year period.
A new continuous glucose monitoring system that allows patients to capture real-time glucose readings without use calibration or routine fingersticks is now available.
Higher childhood body mass index and increases in BMI during childhood are linked to an increased risk of early adult ischemic stroke.
